Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

U.S. In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Instruments), By Technology (Immunoassay, Molecular Diagnostics), By Application, By End-use, And Segment Forecasts, 2020 - 2027

Published by Grand View Research, Inc. Product code 977697
Published Content info 100 Pages
Delivery time: 2-3 business days
Price
Back to Top
U.S. In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Instruments), By Technology (Immunoassay, Molecular Diagnostics), By Application, By End-use, And Segment Forecasts, 2020 - 2027
Published: December 1, 2020 Content info: 100 Pages
Description

U.S. In Vitro Diagnostics Market Growth & Trends:

The U.S. in vitro diagnostics market size is expected to reach USD 37.35 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.0% from 2020 to 2027. The prevalence of various diseases such as cancer, autoimmune diseases, and inflammatory conditions is increasing, which is expected to drive the market. For instance, according to the American Cancer Society, about 1.8 million are estimated to be new cancer cases and around 606,520 individuals are projected to die in 2020. Breast, prostate, colorectal, lung, stomach, and liver cancers are the most common types.

In addition, cell counts are performed manually; however, companies are introducing automated instruments to reduce manual work and provide quick and accurate results. For instance, in July 2018, Sysmex America, Inc. entered into a partnership with Advanced Instruments to introduce a novel GloCyte Automated Cell Counter System that is used to detect cerebrospinal fluid cell count. As per this agreement, Sysmex America, Inc. would be the exclusive distributor of the system in the U.S.

Increasing use of approved blood-gas analyzers to monitor respiratory conditions is expected to fuel market growth. For instance, in March 2020, Siemens Healthineers AG received the U.S. FDA approval for the RapidPoint 500e blood gas analyzer. This blood gas analyzer can be used for critically ill patients under acute care. Furthermore, it is anticipated to support COVID-19 response efforts due to its ability to test blood gas, which, in turn, is expected to help manage infected patients by aiding the monitoring of their respiratory conditions.

An increase in the initiatives by organizations to improve patient outcomes using cost-effective and rapid diagnostic techniques to help fight antibiotic resistance is expected to fuel market growth. For instance, in April 2019, The University of Antwerp, Wellcome Trust, and bioMerieux, together launched Value-Dx-an Innovative Medicines Initiative (IMI) project-that was initiated by six IVD companies to fight against antimicrobial resistance. The aim of this project was to transform clinical practice and achieve better patient outcomes by implementing new diagnostic technologies.

U.S. In Vitro Diagnostics Market Report Highlights:

  • By technology, the molecular diagnostics segment is expected to be the fastest-growing segment over the forecast period owing to the rising number of approvals by regulatory authorities and the presence of various technologies, such as Polymerase Chain Reaction (PCR), mass spectroscopy, and Isothermal Nucleic Acid Amplification Technology (INAAT)
  • The immunoassays technology segment held the largest market share in 2019 due to the increasing adoption of immunoassay-based POC testing and rapid testing and growing use of tests and expansion of assay menu
  • Based on end use, the hospitals segment dominated the market in 2019 owing to the availability of a large number of community hospitals, federal government hospitals, and nonfederal psychiatric hospitals and developed infrastructure
  • The presence of key players and rising initiatives to raise awareness among healthcare professionals and patients are fueling the market growth
Table of Contents
Product Code: GVR-4-68039-256-6

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Product
    • 1.1.2 Technique
    • 1.1.3 Application
    • 1.1.4 End Use
    • 1.1.5 Country scope
    • 1.1.6 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume price analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume price analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 U.S. In Vitro Diagnostics (IVD) Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Regulatory Framework
    • 3.3.1 Market Driver Analysis
    • 3.3.2 Growing geriatric population
    • 3.3.3 Technological advancements
    • 3.3.4 Increasing demand for POC facilities
    • 3.3.5 Growing prevalence of target diseases, such as genetic, cardiovascular, and neurological diseases, and hospital-acquired infections
    • 3.3.6 Outbreak of covid-19
  • 3.4 Market Restraint Analysis
    • 3.4.1 Higher cost of devices
    • 3.4.2 Stringent regulatory policies
  • 3.5 SWOT Analysis, by factor (Political & Legal, Economic, and Technological)
  • 3.6 Porter's Five Forces Analysis
  • 3.7 Major deals and strategic alliances analysis
    • 3.7.1. New product launch
    • 3.7.2. Mergers and acquisitions
    • 3.7.3. Expansion
    • 3.7.4. Partnerships
    • 3.7.5. Marketing & promotions
    • 3.7.6. Market entry strategies
  • 3.8 Mergers and Deals

Chapter 4 U.S. In Vitro Diagnostics (IVD) Market: Segment Analysis, By Product, 2016 - 2027 (USD Million)

  • 4.1 Definition and Scope
  • 4.2 Product Market Share Analysis, 2019 & 2027
  • 4.3 Segment Dashboard
  • 4.4 U.S. In Vitro Diagnostics (IVD) Market, by Product, 2016 to 2027
  • 4.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
    • 4.5.1 Instruments
      • 4.5.1.1 Instruments market estimates and forecast, 2016 - 2027
    • 4.5.2 Reagents
      • 4.5.2.1 Reagents market estimates and forecast, 2016 - 2027
    • 4.5.3 Services
      • 4.5.3.1 Services market estimates and forecast, 2016 - 2027

Chapter 5 U.S. In Vitro Diagnostics (IVD) Market: Segment Analysis, By Technology, 2016 - 2027 (USD Million)

  • 5.1 Definition and Scope
  • 5.2 Technology Market Share Analysis, 2019 & 2027
  • 5.3 Segment Dashboard
  • 5.4 U.S. In Vitro Diagnostics (IVD) Market, by Technology, 2016 to 2027
  • 5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
    • 5.5.1 Immunoassay
      • 5.5.1.1 Immunoassay market estimates and forecast, 2016 - 2027
      • 5.5.1.2 Instruments
      • 5.5.1.2.1 Instruments market for immunoassay estimates and forecast, 2016 - 2027
      • 5.5.1.3 Reagents
      • 5.5.1.3.1 Reagents market for immunoassay estimates and forecast, 2016 - 2027
      • 5.5.1.4 Services
      • 5.5.1.4.1 Services market for immunoassay estimates and forecast, 2016 - 2027
    • 5.5.2 Hematology
      • 5.5.2.1 Hematology market estimates and forecast, 2016 - 2027
      • 5.5.2.2 Instruments
      • 5.5.2.2.1 Instruments market for hematology estimates and forecast, 2016 - 2027
      • 5.5.2.3 Reagents
      • 5.5.2.3.1 Reagents market for hematology estimates and forecast, 2016 - 2027
      • 5.5.2.4 Services
      • 5.5.2.4.1 Services market for hematology estimates and forecast, 2016 - 2027
    • 5.5.3 Clinical Chemistry
      • 5.5.3.1 Clinical Chemistry market estimates and forecast, 2016 - 2027
      • 5.5.3.2 Instruments
      • 5.5.3.2.1 Instruments market for clinical chemistry estimates and forecast, 2016 - 2027
      • 5.5.3.3 Reagents
      • 5.5.3.3.1 Reagents market for clinical chemistry estimates and forecast, 2016 - 2027
      • 5.5.3.4 Services
      • 5.5.3.4.1 Services market for clinical chemistry estimates and forecast, 2016 - 2027
    • 5.5.4 Molecular Diagnostics
      • 5.5.4.1 Molecular diagnostics market estimates and forecast, 2016 - 2027
      • 5.5.4.2 Instruments
      • 5.5.4.2.1 Instruments market for molecular diagnostics estimates and forecast, 2016 - 2027
      • 5.5.4.3.Reagents
      • 5.5.4.3.1 Reagents market for molecular diagnostics estimates and forecast, 2016 - 2027
      • 5.5.4.4 Services
      • 5.5.4.4.1 Services market for molecular diagnostics estimates and forecast, 2016 - 2027
    • 5.5.4 Coagulation
      • 5.5.4.1 Coagulation market estimates and forecast, 2016 - 2027
    • 5.5.4 2 Instruments
    • 5.5.4 2.1 Instruments market for coagulation estimates and forecast, 2016 - 2027
    • 5.5.4 3 Reagents
    • 5.5.4 3.1 Reagents market for coagulation estimates and forecast, 2016 - 2027
    • 5.5.4 4 Services
    • 5.5.4 4.1 Services market for coagulation estimates and forecast, 2016 - 2027
    • 5.5.5 Microbiology
      • 5.5.4.1 Microbiology market estimates and forecast, 2016 - 2027
      • 5.5.4.2 Instruments
      • 5.5.4.2.1 Instruments market for microbiology estimates and forecast, 2016 - 2027
      • 5.5.4.3 Reagents
      • 5.5.4.3.1 Reagents market for microbiology estimates and forecast, 2016 - 2027
      • 5.5.4.4 Services
      • 5.5.4.4.1 Services market for microbiology estimates and forecast, 2016 - 2027
    • 5.5.5 Others
      • 5.5.5.1 Others market estimates and forecast, 2016 - 2027
      • 5.5.5.2 Instruments
      • 5.5.5.2.1 Instruments Others market estimates and forecast, 2016 - 2027
      • 5.5.5.3 Reagents
      • 5.5.5.3.1 Reagents market estimates and forecast, 2016 - 2027
      • 5.5.5.4 Services
      • 5.5.5.4.1 Services market for other technology estimates and forecast, 2016 - 2027

Chapter 6 U.S. In Vitro Diagnostics (IVD) Market: Segment Analysis, By Application, 2016 - 2027 (USD Million)

  • 6.1 Definition and Scope
  • 6.2 Application Market Share Analysis, 2019 & 2027
  • 6.3 Segment Dashboard
  • 6.4 U.S. In Vitro Diagnostics (IVD) Market, by Application, 2016 to 2027
  • 6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
    • 6.5.1 Infectious Diseases
      • 6.5.1.1 Infectious Diseases market estimates and forecast, 2016 - 2027
    • 6.5.2 Diabetes
      • 6.5.2.1 Diabetes market estimates and forecast, 2016 - 2027
    • 6.5.3 Oncology
      • 6.5.3.1 Oncology market estimates and forecast, 2016 - 2027
    • 6.5.4 Cardiology
      • 6.5.4.1 Cardiology market estimates and forecast, 2016 - 2027
    • 6.5.5 Nephrology
      • 6.5.5.1 Nephrology market estimates and forecast, 2016 - 2027
    • 6.5.6 Autoimmune Diseases
      • 6.5.6.1 Autoimmune Diseases market estimates and forecast, 2016 - 2027
    • 6.5.7 Drug Testing
      • 6.5.7.1 Drug Testing market estimates and forecast, 2016 - 2027
    • 6.5.8 Others
      • 6.5.8.1 Others market estimates and forecast, 2016 - 2027

Chapter 7 U.S. In Vitro Diagnostics (IVD) Market: Segment Analysis, By End Use, 2016 - 2027 (USD Million)

  • 7.1 Definition and Scope
  • 7.2 End-use Market Share Analysis, 2019 & 2027
  • 7.3 Segment Dashboard
  • 7.4 U.S. In Vitro Diagnostics (IVD) Market, by End Use, 2016 to 2027
  • 7.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
    • 7.5.1 Hospitals
      • 7.5.1.1 Hospitals market estimates and forecast, 2016 - 2027
      • 7.5.1.2 Hospitals U.S. IVD instrument market estimates and forecast, 2016 - 2027
    • 7.5.2 Laboratories
      • 7.5.2.1 Laboratories Market estimates and forecast, 2016 - 2027
      • 7.5.2.2 Laboratories U.S. IVD instrument market estimates and forecast, 2016 - 2027
    • 7.5.3 Home-care
      • 7.5.3.1 Home-care Market estimates and forecast, 2016 - 2027
      • 7.5.3.2 Home-care U.S. IVD instrument market estimates and forecast, 2016 - 2027
    • 7.5.4 Others
      • 7.5.4.1 Other Market estimates and forecast, 2016 - 2027
      • 7.5.4.2 Other U.S. IVD instrument market estimates and forecast, 2016 - 2027

Chapter 8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 8.1.1 Ansoff matrix
    • 8.1.2 Company/Competition Categorization (Key innovators, Market leaders, Expansion)
    • 8.1.3 Innovators
  • 8.2 Vendor Landscape
    • 8.2.1 List of key distributors and channel partners
    • 8.2.2 Key company market share analysis, 2018
  • 8.3 Public Companies
    • 8.3.1 Company market position analysis
    • 8.3.2 Competitive Dashboard Analysis
    • 8.3.3 Strategic FramewoRk
  • 8.4 Private Companies
    • 8.4.1 List of key emerging companies /technology disruptors/innovators
    • 8.4.2 Regional network map
  • 8.5 Company Profiles
    • 8.5.1 Abbott
      • 8.5.1.1 Company overview
      • 8.5.1.2 Financial performance
      • 8.5.1.3 Product benchmarking
      • 8.5.1.4 Strategic initiatives
    • 8.5.2 bioMerieux SA
      • 8.5.2.1 Company overview
      • 8.5.2.2 Financial Performance
      • 8.5.2.3 Product benchmarking
      • 8.5.2.4 Strategic initiatives
    • 8.5.3 Bio-Rad Laboratories, Inc.
      • 8.5.3.1 Company overview
      • 8.5.3.2 Financial Performance
      • 8.5.3.3 Product benchmarking
      • 8.5.3.4 Strategic initiatives
    • 8.5.4 Becton, Dickinson and Company
      • 8.5.4.1 Company overview
      • 8.5.4.2 Financial performance
      • 8.5.4.3 Product benchmarking
      • 8.5.4.4 Strategic initiatives
    • 8.5.5 Siemens Healthineers AG
      • 8.5.5.1 Company overview
      • 8.5.5.2 Financial Performance
      • 8.5.5.3 Product benchmarking
      • 8.5.5.4 Strategic initiatives
    • 8.5.6 Qiagen
      • 8.5.6.1 Company overview
      • 8.5.6.2 Financial performance
      • 8.5.6.3 Product benchmarking
      • 8.5.6.4 Strategic initiatives
    • 8.5.7 Quidel Corporation
      • 8.5.7.1 Company overview
      • 8.5.7.2 Financial performance
      • 8.5.7.3 Product benchmarking
      • 8.5.7.4 Strategic initiatives
    • 8.5.8 F. Hoffmann-La Roche AG
      • 8.5.8.1 Company overview
      • 8.5.8.2 Financial performance
      • 8.5.8.3 Product benchmarking
      • 8.5.8.4 Strategic initiatives
    • 8.5.9 Sysmex Corporation
      • 8.5.9.1 Company overview
      • 8.5.9.2 Financial performance
      • 8.5.9.3 Product benchmarking
      • 8.5.9.4 Strategic initiatives
    • 8.5.10 Charles River Laboratories International, Inc.
      • 8.5.10.1 Company overview
      • 8.5.10.2 Financial performance
      • 8.5.10.3 Product benchmarking
      • 8.5.10.4 Strategic initiatives
    • 8.5.11 Quest Diagnostics
      • 8.5.11.1 Company overview
      • 8.5.11.2 Financial performance
      • 8.5.11.3 Product benchmarking
      • 8.5.11.4 Strategic initiatives
    • 8.5.12 Agilent Technologies
      • 8.5.12.1 Company overview
      • 8.5.12.2 Financial performance
      • 8.5.12.3 Product benchmarking
      • 8.5.12.4 Strategic initiatives
    • 8.5.13 Danaher Corporation
      • 8.5.13.1 Company overview
      • 8.5.13.2 Financial performance
      • 8.5.13.3 Product benchmarking
      • 8.5.13.4 Strategic initiatives
      • 8.5.13.5 Strategic initiatives- Beckman Coulter, Inc.
      • 8.5.13.6 Strategic initiatives- Leica Biosystems

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of Abbreviation
  • TABLE 3 Regulatory framework
  • TABLE 4 EUA IVD tests for COVID-19
  • TABLE 5 List of key distributors
  • TABLE 6 List of key emerging companies /technology disruptors/innovators
  • TABLE 7 U.S. IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 8 U.S. IVD Instrument Market, Type of Test, 2016 - 2027 Volume (Number of Units Installed)
  • TABLE 9 U.S. IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 10 U.S. Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 11 U.S. Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 12 U.S. Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 13 U.S. Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 14 U.S. Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 15 U.S. Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 16 U.S. Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 17 U.S. IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 18 U.S. IVD Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 19 U.S. IVD Instrument Market, Type of Provider, 2016 - 2027 Volume (Number of Units Installed)

List of Figures

  • FIG. 1 U.S. In Vitro Diagnostics Market Segmentation
  • FIG. 2 Market research process
  • FIG. 3 Data triangulation techniques
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value-chain-based sizing & forecasting
  • FIG. 7 QFD modeling for market share assessment
  • FIG. 8 Market formulation & validation
  • FIG. 9 U.S. In vitro diagnostic market snapshot
  • FIG. 10 Parent market outlook
  • FIG. 11 Penetration and growth prospect mapping
  • FIG. 12 U.S. In vitro diagnostic market driver impact
  • FIG. 13 U.S. population by age group, 2016 & 2027
  • FIG. 14 U.S. In vitro diagnostic market restraint impact
  • FIG. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • FIG. 16 Porter's Five Forces Analysis
  • FIG. 17 Strategy mapping
  • FIG. 18 U.S. IVD market: Product outlook and key takeaways
  • FIG. 19 U.S. IVD market: Product movement analysis
  • FIG. 20 Instruments market estimates and forecast, 2016 - 2027
  • FIG. 21 Reagents market estimates and forecast, 2016 - 2027
  • FIG. 22 Services market estimates and forecast, 2016 - 2027
  • FIG. 23 U.S. IVD market: Technology outlook and key takeaways
  • FIG. 24 U.S. IVD Market: Technology Movement Analysis
  • FIG. 25 Immunoassay market estimates and forecast, 2016 - 2027
  • FIG. 26 Instruments market for immunoassay estimates and forecast, 2016 - 2027
  • FIG. 27 Reagents market for immunoassay estimates and forecast, 2016 - 2027
  • FIG. 28 Services market for immunoassay estimates and forecast, 2016 - 2027
  • FIG. 29 Hematology market estimates and forecast, 2016 - 2027
  • FIG. 30 Instruments market for hematology estimates and forecast, 2016 - 2027
  • FIG. 31 Reagents market for hematology estimates and forecast, 2016 - 2027
  • FIG. 32 Services market for hematology estimates and forecast, 2016 - 2027
  • FIG. 33 Clinical chemistry market estimates and forecast, 2016 - 2027
  • FIG. 34 Instruments market for clinical chemistry estimates and forecast, 2016 - 2027
  • FIG. 35 Reagents market for clinical chemistry estimates and forecast, 2016 - 2027
  • FIG. 36 Services market for clinical chemistry estimates and forecast, 2016 - 2027
  • FIG. 37 Molecular diagnostics market estimates and forecast, 2016 - 2027
  • FIG. 38 Instruments market for molecular diagnostics estimates and forecast, 2016 - 2027
  • FIG. 39 Reagents market for molecular diagnostics estimates and forecast, 2016 - 2027
  • FIG. 40 Services market for molecular diagnostics estimates and forecast, 2016 - 2027
  • FIG. 41 Coagulation market estimates and forecast, 2016 - 2027
  • FIG. 42 Instruments market for coagulation estimates and forecast, 2016 - 2027
  • FIG. 43 Reagents market for coagulation estimates and forecast, 2016 - 2027
  • FIG. 44 Services market for coagulation estimates and forecast, 2016 - 2027
  • FIG. 45 Microbiology market estimates and forecast, 2016 - 2027
  • FIG. 46 Instruments market for microbiology estimates and forecast, 2016 - 2027
  • FIG. 47 Reagents market for microbiology estimates and forecast, 2016 - 2027
  • FIG. 48 Services market for microbiology estimates and forecast, 2016 - 2027
  • FIG. 49 Others market estimates and forecast, 2016 - 2027
  • FIG. 50 Instruments market for other technology estimates and forecast, 2016 - 2027
  • FIG. 51 Reagents market for other technology estimates and forecast, 2016 - 2027
  • FIG. 52 Services market for other technology estimates and forecast, 2016 - 2027
  • FIG. 53 U.S. IVD market: Application outlook and key takeaways
  • FIG. 54 U.S. IVD market: Application movement analysis
  • FIG. 55 Infectious diseases market estimates and forecast, 2016 - 2027
  • FIG. 56 Diabetes market estimates and forecast, 2016 - 2027
  • FIG. 57 Oncology market estimates and forecast, 2016 - 2027
  • FIG. 58 Cardiology market estimates and forecast, 2016 - 2027
  • FIG. 59 Nephrology market estimates and forecast, 2016 - 2027
  • FIG. 60 Autoimmune diseases market estimates and forecast, 2016 - 2027
  • FIG. 61 Drug Testing market estimates and forecast, 2016 - 2027
  • FIG. 62 Others market estimates and forecast, 2016 - 2027
  • FIG. 63 U.S. IVD market: End-use outlook and key takeaways
  • FIG. 64 U.S. IVD treatment market: End-use movement analysis
  • FIG. 65 Hospitals market estimates and forecast, 2016 - 2027
  • FIG. 66 Hospitals U.S. IVD instrument market estimates and forecast, 2016 - 2027 (USD Million)
  • FIG. 67 Laboratories market estimates and forecast, 2016 - 2027
  • FIG. 68 Laboratories U.S. IVD instrument market estimates and forecast, 2016 - 2027 (USD Million)
  • FIG. 69 Home-care market estimates and forecast, 2016 - 2027
  • FIG. 70 Home-care U.S. IVD instrument market estimates and forecast, 2016 - 2027 (USD Million)
  • FIG. 71 Other market estimates and forecast, 2016 - 2027
  • FIG. 72 Other U.S. IVD instrument market estimates and forecast, 2016 - 2027 (USD Million)
  • FIG. 73 Ansoff Matrix
  • FIG. 74 Competition Categorization
  • FIG. 75 Company market share analysis
  • FIG. 76 Company market position analysis
  • FIG. 77 Company market position analysis
  • FIG. 78 Company market position analysis
  • FIG. 79 Company profiles
  • FIG. 80 Regional Network Map
Back to Top